In this regard, we had the opportunity to evaluate humoral, B and CD4+ T cell–mediated spike-specific immune response in 14 (7 naive and 7 recovered from COVID-19) individuals before and 1 week after the administration of the booster dose. This evidence concerns the gene CD4 and COVID-19.